A Phase 1/2 Study of VX-670 in Adult Subjects with Myotonic Dystrophy Type 1
Brief description of study
Please refer to Protocol V2.2, Version date 12Feb2024, Section 6.2 (Study Objectives Part B) on page 28 for a full list of primary, secondary, and other exploratory objectives. Please refer to Protocol V2.2, Version date 12Feb2024, Section 7.2 (Study Endpoints Part B) on page 29 for a full list of primary endpoint variables. Please refer to Protocol V2.2, Version date 12Feb2024, Section 7.2 (Study Endpoints Part B) on pages 29 and 30 for a full list of secondary and other exploratory endpoint variables.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
